(Q41530675)

2 October 2017

1 reference

title

Pharmacotherapies for alcohol abuse. Withdrawal and treatment (English)

1 reference

2 October 2017

0 references

Saitz R

1

1 reference

2 October 2017

O'Malley SS

series ordinal

2

1 reference

2 October 2017

publication date

1 July 1997

1 reference

Medical Clinics of North America

2 October 2017

published in

1 reference

2 October 2017

volume

81

1 reference

2 October 2017

issue

4

1 reference

2 October 2017

page(s)

881-907

1 reference

Status epilepticus related to alcohol abuse

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Correlates of outcome in disulfiram treatment of alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Kindling as a Model for Alcohol Withdrawal Syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Clonidine vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Quantification of the alcohol withdrawal syndrome in 487 alcoholic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alpha-atrial natriuretic peptide, aldosterone secretion and plasma renin activity during ethanol withdrawal: a correlation with the onset of delirium tremens?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Clonidine in alcohol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Ambulant treatment of alcohol withdrawal symptoms with carbamazepine: a formal multicentre doubl-blind comparison with placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Severity and treatment of alcohol withdrawal in elderly versus younger patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Screening for alcohol abuse using CAGE scores and likelihood ratios

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol consumption patterns in a primary care population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Physician detection of drinking problems in patients attending a general medicine practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Emergency department treatment of alcohol withdrawal seizures with phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Carbamazepine: Prevention of alcohol withdrawal seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Varying rates of alcohol metabolism in relation to detoxification medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Acamprosate modulates synaptosomal GABA transmission in chronically alcoholised rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Risk factors for delirium tremens development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Use of an objective clinical scale in the assessment and management of alcohol withdrawal in a large general hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol research: at the cutting edge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol consumption, alcohol abuse and alcohol dependence. The United States as an example

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Drug therapy. Current status of benzodiazepines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Relative Abuse Liability of Different Benzodiazepines in

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Wernicke's encephalopathy: a more common disease than realised. A neuropathological study of 51 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Posttreatment depression in an alcohol and drug abuse population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Hazards associated with the use of benzodiazepines in alcohol detoxification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Current treatment for alcohol withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Treatment of the pregnant alcohol-dependent woman

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Treatment of the acute alcohol withdrawal state: a comparison of four drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

New drug counters alcohol intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Delirium tremens: a double-blind comparison of diazepam and barbital treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Randomized clinical trial of atenolol in patients with alcohol withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Relative kindling effect of detoxification and non-detoxification admissions in alcoholics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

A Clinical Comparison of Disulfiram and Calcium Carbimide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Acamprosate appears to decrease alcohol intake in weaned alcoholics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

The benzodiazepine receptor inverse agonists FG 7142 and RO 15-4513 both reverse some of the behavioral effects of ethanol in a holeboard test.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol antagonists--the continuing quest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

The first drink: psychobiological aspects of craving

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Disulfiram treatment of alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Late-onset seizures in alcohol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Magnesium and its therapeutic uses: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Effects of alcohol ingestion and withdrawal on magnesium states of alcoholics: clinical and experimental findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Ritanserin decreases alcohol intake in chronic alcoholics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

The definition of alcoholism. The Joint Committee of the National Council on Alcoholism and Drug Dependence and the American Society of Addiction Medicine to Study the Definition and Criteria for the Diagnosis of Alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

A prediction model for identifying alcohol withdrawal seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Deficiencies of Clinical Trials of Alcohol Withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Nonpharmacologic intervention in acute alcohol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

The serotonin uptake inhibitor citalopram attenuates ethanol intake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Imipramine treatment of alcoholism with comorbid depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Naltrexone in the treatment of alcoholism: a clinical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Social and clinical features as predictors of outcome in outpatient alcohol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Six-month follow-up of naltrexone and psychotherapy for alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Experience of a "slip" among alcoholics treated with naltrexone or placebo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol withdrawal syndromes - prediction from detailed medical and drinking histories.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Kindling: the first decade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Comparison of two benzodiazepines in the treatment of alcohol withdrawal: effects on symptoms and cognitive recovery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Magnesium deficiency in a medical ICU population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Recognition and management of occult alcohol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol withdrawal: a nationwide survey of inpatient treatment practices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Diazepam loading: simplified treatment of alcohol withdrawal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Drug therapy: Drugs to decrease alcohol consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

COMPARATIVE CLINICAL EVALUATION OF CHLORDIAZEPOXIDE AND PROMAZINE IN TREATMENT OF ALCOHOL-WITHDRAWAL SYNDROME.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Use of benzodiazepines in anxiety disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Tiapride in the long-term management of alcoholics of anxious or depressive temperament.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Development of Optimal Treatment Tactics for Alcohol Withdrawal. I. Assessment and Effectiveness of Supportive Care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Evaluation of a social-setting detoxication program

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Reduction in early alcohol abstinence fits by administration of carbamazepine syrup instead of tablets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Home detoxification from alcohol: its safety and efficacy in comparison with inpatient care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

The severity of alcohol dependence questionnaire: its use, reliability and validity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Naltrexone-induced alterations in human ethanol intoxication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Diazepam and paraldehyde for treatment of severe delirium tremens. A controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

The glutamatergic basis of human alcoholism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol withdrawal syndromes: a review of pathophysiology, clinical presentation, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Naltrexone in the treatment of alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Effect of naltrexone on alcohol "high" in alcoholics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Detoxification of alcoholics: improving care by symptom-triggered sedation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Clinical Predictors of Alcohol Withdrawal Delirium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Magnesium depletion as a cause of refractory potassium repletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Comparison of acamprosate and placebo in long-term treatment of alcohol dependence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Alcoholic Hypoglycemia and Ketoacidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Double-blind trial of alprazolam and chlordiazepoxide in the management of the acute ethanol withdrawal syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

A toxicity study of parenteral thiamine hydrochloride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Propranolol and Chlordiazepoxide Effects on Cardiac Arrhythmias During Alcohol Withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2805%2970554-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-7125(05)70554-X

1 reference

2 October 2017

1 reference